Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Haematologica. 2021 Feb 1;106(2):601-604. doi: 10.3324/haematol.2019.239756.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis* / diagnosis
  • Amyloidosis* / genetics
  • Humans
  • Immunoglobulin Light Chains / genetics
  • Immunoglobulin Light-chain Amyloidosis* / diagnosis
  • Immunoglobulin Light-chain Amyloidosis* / genetics
  • Mutation
  • Pathology, Molecular
  • Plasma Cells

Substances

  • Immunoglobulin Light Chains

Grant support

Funding: this work was supported by the Ministry of Health of the Czech Republic (15-29667A).